Hearing News Watch

MILAN, ITALY –– Time Magazine, in collaboration with market insights firm Statista, has included Amplifon among its list of the best companies in the world. The rankings name 750 of the 10,000 major companies taken into consideration, each with a minimum annual turnover of $100 million and presence on at least two world regions. Amplifon comes under the Engineering, Manufacturing and

A recent study conducted at Washington University in St. Louis has made significant strides in understanding Meniere’s disease and tailoring treatment approaches to individual patients. Led by Brevin J. Miller and his colleagues, the research aimed to identify the crucial factors influencing treatment responses in Meniere’s disease patients and create a composite clinical severity staging system to aid in more

Hearing Health & Technology Matters (HHTM), an online resource for hearing professionals and consumers with hearing loss, today announces the opening of the public voting period for the 4th annual Hearing Technology Innovator Awards™. Through the international awards program, HHTM honors technological innovation and achievement in the hearing industry. Categories and Awards For 2023, the awards will be conferred in

MILAN, ITALY – Enrico Vita, the Chief Executive Officer of Amplifon, a leading player in hearing solutions, has been named “Best CEO” in the European Medical Technology & Services (MedTech) sector by the esteemed Institutional Investor. The accolade comes as part of the annual “All-Developed Europe Executive Team” ranking by Institutional Investor, an independent research institution in the field of

SEATTLE, WASHINGTON — SafKan Health, the makers of the FDA-cleared OtoSet® Ear Cleaning System, has announced the appointment of Susan Whichard as Vice President of Commercialization (PT) and Scott Krell as Senior Director of Research & Development. Susan Whichard, in a part-time capacity, will support SafKan Health’s efforts in cultivating strategic relationships. Her role will accelerate clinical research and collaborations

BALLERUP, DENMARK — In a significant strategic move, the GN Group has announced plans to begin consolidation and integration across its two prominent business divisions, GN Hearing and GN Audio. The integration aims to harness collaborative innovation and synergistic scalability for enhanced growth and profitability. GN’s Board of Directors has now decided to execute the next step of integration and

In a remarkable breakthrough, an international team of scientists led by researchers at University College London (UCL) and the NIHR Great Ormond Street Hospital Biomedical Research Centre has developed a groundbreaking gene therapy in mice that significantly mitigates the hearing loss associated with Norrie disease, a rare and debilitating genetic disorder. Norrie disease primarily afflicts boys, causing blindness from birth

CHICAGO, ILLINOIS – Newsweek has announced Beltone as part of America’s Best Customer Service in Hearing Care for 2024. This acknowledgment coincides with Beltone’s launch of an online resource center, “Healthy Aging,” in celebration of Healthy Aging Month in September. “At Beltone, we are dedicated to empowering individuals to maintain optimal hearing health and overall well-being. Newsweek’s recognition for two

COPENHAGEN, DENMARK — In an announcement this week, Demant has revealed its strategic decision to gradually wind down its Gaming division while intensifying its commitment to the core sector of Enterprise Solutions under the EPOS brand within its Communications segment. The decision follows a comprehensive evaluation of the potential for growth and competitiveness in the Gaming sector, following a period

SOUTH SAN FRANCISCO, CALIFORNIA — Spiral Therapeutics, Inc., a clinical-stage company focused on delivering therapies for inner ear disorders, today announced a new round of financing led by Esperante Ventures and Ferring Ventures SA. This infusion of capital will propel the company’s innovative approach to treating inner ear disorders, including the collection of additional clinical data for its lead program